Gene · 3818
Papers2,245
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,245
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering the Impact of ZnO Nanoparticles and a Sunscreen Product Containing ZnO on Phosphorus Dynamics and Release in Chlorella pyrenoidosa in Aquatic Systems. | Environ Sci Technol | 2024 | 38809112 | PubTator, text mining | PubMed |
| Liquid-liquid phase separation of TZP promotes PPK-mediated phosphorylation of the phytochrome A photoreceptor. | Nat Plants | 2024 | 38714768 | PubTator, text mining | PubMed |
| The future of therapeutic options for hereditary angioedema. | Ann Allergy Asthma Immunol | 2024 | 38679158 | PubTator, text mining | PubMed |
| Ppx1 putative exopolyphosphatase is essential for polyphosphate accumulation in Lacticaseibacillus paracasei. | Appl Environ Microbiol | 2024 | 38619267 | PubTator, text mining | PubMed |
| Large Libraries of Structurally Diverse Macrocycles Suitable for Membrane Permeation. | Angew Chem Int Ed Engl | 2024 | 38602024 | PubTator, text mining | PubMed |
| Central subfield thickness of diabetic macular edema: Correlation with the aqueous humor proteome. | Mol Vis | 2024 | 38586604 | PubTator, text mining | PubMed |
| Fluoride-related changes in the fetal cord blood proteome; a pilot study. | Res Sq | 2024 | 38464284 | PubTator, text mining | PubMed |
| Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trial. | World Allergy Organ J | 2024 | 38445295 | PubTator, text mining | PubMed |
| Biomarkers associated with cardiovascular disease in women with spontaneous preterm birth: A case-control study. | Acta Obstet Gynecol Scand | 2024 | 38379394 | PubTator, text mining | PubMed |
| CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema. | N Engl J Med | 2024 | 38294975 | PubTator, text mining | PubMed |
| Engineering a transposon-associated TnpB-ωRNA system for efficient gene editing and phenotypic correction of a tyrosinaemia mouse model. | Nat Commun | 2024 | 38280857 | PubTator, text mining | PubMed |
| Ongoing Analytical Procedure Performance Verification Using a Risk-Based Approach to Determine Performance Monitoring Requirements. | Anal Chem | 2024 | 38191128 | PubTator, text mining | PubMed |
| Clinical Progress in Hepatic Targeting for Novel Prophylactic Therapies in Hereditary Angioedema. | J Allergy Clin Immunol Pract | 2024 | 38142864 | PubTator, text mining | PubMed |
| Different survival strategies of the phosphate-mineralizing bacterium Enterobacter sp. PMB-5 in response to cadmium stress: Biomineralization, biosorption, and bioaccumulation. | J Hazard Mater | 2024 | 38134699 | PubTator, text mining | PubMed |
| Proteomics Analysis of Serum Reveals Potential Biomarkers for Heart Failure Patients with Phlegm-Blood Stasis Syndrome. | J Proteome Res | 2024 | 38048169 | PubTator, text mining | PubMed |
| Proteomic insights into modifiable risk of venous thromboembolism and cardiovascular comorbidities. | J Thromb Haemost | 2024 | 38029854 | PubTator, text mining | PubMed |
| A mechanism for hereditary angioedema caused by a methionine-379-to-lysine substitution in kininogens. | Blood | 2024 | 37992228 | PubTator, text mining | PubMed |
| Spliceosome malfunction causes neurodevelopmental disorders with overlapping features. | J Clin Invest | 2024 | 37962958 | PubTator, text mining | PubMed |
| Tackling the Root Cause of Surface-Induced Coagulation: Inhibition of FXII Activation to Mitigate Coagulation Propagation and Prevent Clotting. | Macromol Biosci | 2024 | 37742317 | PubTator, text mining | PubMed |
| Factor XII Structure-Function Relationships. | Semin Thromb Hemost | 2024 | 37276883 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3818/papers?page=5